Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: The deleterious effects of cannabis during pregnancy on neonatal outcomes
Author: Grzeskowiak, L.E.
Grieger, J.A.
Andraweera, P.
Knight, E.J.
Leemaqz, S.
Poston, L.
McCowan, L.
Kenny, L.
Myers, J.
Walker, J.J.
Dekker, G.A.
Roberts, C.T.
Citation: The Medical journal of Australia, 2020; 212(11):519-524
Publisher: Wiley; Australasian Medical Publishing Company
Issue Date: 2020
ISSN: 0025-729X
Statement of
Luke E Grzeskowiak, Jessica A Grieger, Prabha Andraweera, Emma J Knight, Shalem Leemaqz, Lucilla Poston, Lesley McCowan, Louise Kenny, Jenny Myers, James J Walker, Gustaaf A Dekker, Claire T Roberts
Abstract: Objectives: To evaluate whether cannabis use during pregnancy is associated with adverse neonatal outcomes that are independent of cigarette smoking. Design: Prospective cohort study. Setting: Adelaide (Australia), Auckland (New Zealand), Cork (Ireland), and Leeds, London and Manchester (United Kingdom). Participants: 5610 pregnant nulliparous women with low risk pregnancies recruited for the Screening for Pregnancy Endpoints (SCOPE) study, November 2004 – February 2011. At 14–16 weeks of pregnancy, women were grouped by self-reported cannabis use. Main outcome measures: Infant birthweight, head circumference, birth length, gestational age, and severe neonatal morbidity or mortality. Results: 314 women (5.6%) reported using cannabis in the 3 months before or during their pregnancy; 97 (31%) stopped using it before and 157 (50%) during the first 15 weeks of pregnancy, while 60 (19%) were still using cannabis at 15 weeks. Compared with babies of mother who had never used cannabis, infants of those who still used it at 15 weeks had lower mean values for birthweight (adjusted mean difference [aMD], –127 g; 95% CI, –238 to –17 g), head circumference (aMD, –0.5 cm; 95% CI, –0.8 to –0.1 cm), birth length (aMD, –0.8 cm; 95% CI, –1.4 to –0.2 cm), and gestational age at birth (aMD, –8.1 days; 95% CI, –12.1 to –4.0 days). The differences for all outcomes except gestational age were greater for women who used cannabis more than once a week than for those who used it less frequently. Conclusions: Continuing to use cannabis during pregnancy is an independent risk factor for poorer neonatal outcomes.
Keywords: Obstetrics; neonatology; pregnancy; perinatal; marijuana abuse
Rights: © 2020 AMPCo Pty Ltd
RMID: 1000021421
DOI: 10.5694/mja2.50624
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.